HER2 ENRICHED

Clinical trials for HER2 ENRICHED explained in plain language.

Never miss a new study

Get alerted when new HER2 ENRICHED trials appear

Sign up with your email to follow new studies for HER2 ENRICHED, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Promising breast cancer drug trial pulled before starting

Disease control Terminated

This study aimed to see if the drug trastuzumab deruxtecan worked better than standard CDK4/6 inhibitors for people with a specific advanced breast cancer (ER-positive, HER2-low, non-luminal A). It was designed for adults with metastatic disease. However, the trial was withdrawn …

Matched conditions: HER2 ENRICHED

Phase: PHASE3 • Sponsor: Danish Breast Cancer Cooperative Group • Aim: Disease control

Last updated Jun 17, 2026 12:07 UTC

HER2 ENRICHED

Get alerted when new HER2 ENRICHED trials appear

Promising breast cancer drug trial pulled before starting